1HERMANDEZ M R,WENK E J,WEINSTEIN B I,et al.Glucocorticoid target cells in the human outflow pathway autopsy and surgical specimens[J].Invest Ophthalmol Vis Sci,1983,24(12):1612-1616.
2WAX M B,TEZEL G,KAWASE K K,et al.Serum auto antibodies to heat shock proteins in glaucoma patients from Japan and the United States[J].Ophthalmology,2001,108(2):296-302.
3MORRISON J C,JOHNSON E C,CEPURNA W,et al.Understanding mechanisms of pressure-induced optic nerve damage[J].Prog Retin Eye Res,2005,24(2):217-240.
4BENGTSSON B,HEIJL A.Diagnostic sensitivity of fast blue-yellow and standard automated perimetry in early glaucoma:a comparison between different test programs[J].Ophthalmology,2006,113(7):1092-1097.
5RESNIKOFF S,PASCOLINI D,ETYAALE D,et al.Global data on visual impairment in the year 2002[J].Bull World Health Organ,2004,82(11):844-851.
6WADEKAR S A,LI D,PERIYASAMY S,et al.Inhibition of heat shock transcription factor by GR[J].Mol Endocrinol,2001,15(8):1396-1410.
7TRIPATHI R C,PARAPURAM S K,TRIPATHI B J,et al.Corticosteroids and glaucoma risk[J].Drugs Aging,1999,15(6):439-450.
8The advanced glaucoma intervention study investigators. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability[J]. Ophthalmology,1994,101(8):1445-1455.
